Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869921 · ClinicalTrials.gov registry record
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 1,322
- Enrollment target
NCT00869921 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 1,322 participants.
The verdict
NCT00869921 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 1,322 participants
- Enrollment target
Study Summary
Evaluate long-term performance of the 4195 LV Lead. This evaluation is based on the number of lead-related complications occuring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4195 LV Lead and is integrated within Medtronic's post-market surveillance platform.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,322 participants |
| Start Date | 2009-03 |
| Est. Completion | 2018-04-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869921
The ClinicalTrials.gov registry entry for NCT00869921 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00869921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869921 about?
NCT00869921 is a clinical study titled "Model 4195 Left Ventricular (LV) Lead Chronic Performance Study". Evaluate long-term performance of the 4195 LV Lead. This evaluation is based on the number of lead-related complications occuring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition...
What is the current status of trial NCT00869921?
This trial is currently completed. The enrollment target is 1,322 participants. The study started on 2009-03. Estimated completion is 2018-04-03.
Who is sponsoring clinical trial NCT00869921?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.